vTv Therapeutics (VTVT) Return on Sales [ROS] (2014 - 2026)
vTv Therapeutics' Return on Sales [ROS] came in at -25.11% for Q2 2026, up 150692.54 percentage points from -150717.65% a year earlier but down 88.26 percentage points from the prior quarter.
Powered by 
Analysis
vTv Therapeutics (VTVT) Return on Sales [ROS] (2014 - 2026) Analysis & Trends
For FY2024, vTv Therapeutics' Return on Sales [ROS] was -2377.58%.
- Return on Sales [ROS] carries a five-year change of -1621.72 percentage points (FY2019 to FY2024).
- Going back by year, Return on Sales [ROS] was -1116.95% in FY2022 (-576.07 pp), -540.87% in FY2021 (-356.09 pp) and -184.78% in FY2020 (+571.08 pp).
- The five-year range for quarterly Return on Sales [ROS] is -305100.00% (Q2 2023) to 63.15% (Q1 2026).
- Year-over-year, Return on Sales [ROS] increased in three of the last six quarters, with an average year-over-year change of +21506.24 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2024 (a gain of 302814.30 percentage points), and the weakest in Q3 2023 (a drop of 300180.21 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | vTv Therapeutics | 379.35 Mn | 379.35 Mn | - | -25.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.11% |
| Mar 31, 2026 | 63.15% |
| Sep 30, 2025 | -175,382.35% |
| Jun 30, 2025 | -150,717.65% |
| Mar 31, 2025 | -147,388.24% |
| Dec 31, 2024 | -28,776.47% |
| Sep 30, 2024 | -2,399.50% |
| Jun 30, 2024 | -2,285.70% |
| Mar 31, 2024 | -562.70% |
| Sep 30, 2023 | -301,533.33% |
| Jun 30, 2023 | -305,100.00% |
| Mar 31, 2023 | -130,477.78% |
| Dec 31, 2022 | -70,477.78% |
| Sep 30, 2022 | -1,353.12% |
| Jun 30, 2022 | -44,744.44% |
| Mar 31, 2022 | -324.05% |
| Dec 31, 2021 | -123,433.33% |
| Sep 30, 2021 | -53.43% |
| Jun 30, 2021 | -51,888.89% |
| Mar 31, 2021 | -433.64% |
API Access
vTv Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VTVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "VTVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VTVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();